Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
LUMOS PHARMA, INC. | Chief Financial Officer | Common Stock | 0 | $0 | $1.89 | Dec 12, 2024 | Direct |
LUMOS PHARMA, INC. | Chief Financial Officer | Stock Option (Right to Buy) | 0 | Dec 12, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
(LUMO) | LUMOS PHARMA, INC. | Dec 12, 2024 | 10 | $0 | 4 | Dec 13, 2024 | Chief Financial Officer |
(LUMO) | LUMOS PHARMA, INC. | Aug 1, 2024 | 1 | -$410 | 4 | Aug 5, 2024 | Chief Financial Officer |
(LUMO) | LUMOS PHARMA, INC. | Apr 1, 2024 | 3 | $2.06K | 4 | Apr 3, 2024 | Chief Financial Officer |
(LUMO) | LUMOS PHARMA, INC. | Feb 1, 2024 | 1 | -$647 | 4 | Feb 5, 2024 | Chief Financial Officer |
LUMO | LUMOS PHARMA, INC. | Aug 1, 2023 | 1 | -$751 | 4 | Aug 3, 2023 | Chief Financial Officer |
LUMO | LUMOS PHARMA, INC. | Apr 1, 2023 | 1 | -$907 | 4 | Apr 4, 2023 | Chief Financial Officer |
LUMO | LUMOS PHARMA, INC. | Feb 1, 2023 | 3 | $3.12K | 4 | Feb 3, 2023 | Chief Financial Officer |
LUMO | LUMOS PHARMA, INC. | Aug 1, 2022 | 1 | -$1.87K | 4 | Aug 3, 2022 | Chief Financial Officer |
LUMO | LUMOS PHARMA, INC. | Apr 1, 2022 | 1 | -$2.53K | 4 | Apr 5, 2022 | Chief Financial Officer |
LUMO | LUMOS PHARMA, INC. | Feb 1, 2022 | 3 | $9.37K | 4 | Feb 3, 2022 | Chief Financial Officer |
LUMO | LUMOS PHARMA, INC. | Aug 1, 2021 | 2 | $0 | 4 | Aug 3, 2021 | Chief Financial Officer |